TME PHARMA NV (ALTME.PA) Stock Analyst Ratings

Europe • Euronext Paris • EPA:ALTME • NL0015000YE1

0.0774 EUR
+0.01 (+7.35%)
Last: Feb 4, 2026, 07:00 PM
Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to ALTME.PA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 0.11. This target is 35.74% above the current price.
  • ALTME.PA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ALTME.PA.
  • In the previous month the buy percentage consensus was at a similar level.
  • ALTME.PA was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

ALTME.PA Historical Analyst RatingsALTME.PA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -41 -37 -33 -29 -25 -21 -17 -13 -9 -5 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.080.100.110.110.11 - 34.41% 35.74% 35.74% 39.73%

Related screens

ALTME.PA Current Analyst RatingALTME.PA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades

TME PHARMA NV / ALTME.PA FAQ

What is the price target for ALTME stock?

9 analysts have analysed ALTME.PA and the average price target is 0.11 EUR. This implies a price increase of 35.74% is expected in the next year compared to the current price of 0.0774.


What is the consensus rating for ALTME stock?

The consensus rating for TME PHARMA NV (ALTME.PA) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.